![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 32, 29792-29797, August 10, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
From the
Children's Medical Research Institute, 214 Hawkesbury Road, Westmead NSW 2145, Australia, the ¶ Australian
Proteome Analysis Facility, Level 4, Building F7B, Macquarie
University, New South Wales 2109, Australia, and the
§ Faculty of Pharmacy, A15, University of Sydney, New South
Wales 2006, Australia
Received for publication, June 12, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Ral is a small GTPase involved in critical
cellular signaling pathways. The two isoforms, RalA and RalB, are
widely distributed in different tissues, with RalA being enriched in
brain. The best characterized RalA signaling pathways involve RalBP1
and phospholipase D. To investigate RalA signaling in neuronal cells we
searched for RalA-binding proteins in brain. We found at least eight
proteins that bound RalA in a GTP-dependent manner.
Matrix-assisted laser desorption ionization time-of-flight mass
spectrometry (MALDI-TOF MS) identified these as the components of the
exocyst complex. The yeast exocyst is a regulator of polarized
secretion, docking vesicles to regions of the plasma membrane involved
in active exocytosis. We identified the human FLJ10893 protein as the
mammalian homologue of the yeast exocyst protein Sec3p. The exocyst
complex did not contain the previously identified exocyst component
rSec15, but a new homologue of both yeast Sec15p and rSec15, called
KIAA0919. Western blots confirmed that two rat exocyst proteins, rSec6
and rSec8, bound active RalA in nerve terminals, as did RalBP1.
Phospholipase D bound RalA in a nucleotide-independent manner. This
places the RalA signaling system in mammalian nerve terminals, where
the exocyst may act as an effector for activated RalA in directing sites of exocytosis.
The small GTPase RalA is a member of the Ras superfamily of
monomeric 20-30-kDa GTP-binding proteins, which cycle between active
GTP-bound and inactive GDP-bound states. In the GTP-bound state they
interact with target proteins (effectors) to initiate downstream
responses. Their signal transduction is terminated by an intrinsic
GTPase activity, returning them to the GDP-bound state. Two Ral genes
exist in vertebrates, RalA and RalB, sharing 85% amino acid identity
(1). Both proteins have a wide, partly overlapping, tissue
distribution, with highest expression of RalA in brain and platelets
and of RalB in platelets, kidney, and adrenal medulla (2). Both
isoforms are found predominantly on the plasma membrane (3) and on the
membranes of secretory vesicles, and RalA is found particularly on the
membranes of synaptic vesicles in brain (4). The enrichment of RalA in
brain and its localization to synaptic vesicles suggests a role in
vesicle trafficking events in the nerve terminal.
Ral activation has mainly been characterized in the downstream
signaling pathways from activated receptor-linked tyrosine kinases and
seven-transmembrane domain receptors, which lead to the activation of
Ras (5). Activation of small GTPases is achieved via guanine nucleotide
exchange factors (GEFs)1 that
facilitate exchange of GDP for GTP. The best known Ral activating pathway is via Ras activating the RalGEF and Ras effector protein Ral
guanine nucleotide dissociation stimulator (RalGDS), but
Ras-independent mechanisms for Ral activation are likely (5, 6). Ral
can also be regulated by intracellular Ca2+ (7).
Ca2+ activates calmodulin, and the complex directly binds
to a polybasic region near the C terminus of RalA (8).
Ca2+-calmodulin binding stimulates GTP binding to RalA,
suggesting that it is a RalA activator (9). In vitro studies
suggest that Ca2+-calmodulin controls RalA subcellular
localization, since binding dissociates RalA from synaptic vesicles
(10).
RalA downstream signaling is mediated by two additional protein-protein
interaction sites. The first binds phospholipase D1 (PLD1) via an
N-terminal 11 amino acid sequence. Ral weakly stimulates PLD1 activity
but operates synergistically with another small GTPase, Arf (11). PLD1
binding to RalA is independent of the nucleotide binding status of
RalA, but signaling pathways that lead to RalA activation also lead to
phosphatidic acid production by PLD (12). The second is an effector
binding loop, which mediates interaction of proteins with RalA in a
GTP-dependent manner. Two proteins are known to interact
with RalA in this fashion, leading to RalA-dependent
cellular effects. Ral-binding protein 1 or RalBP1 (13) is involved in
receptor-mediated endocytosis through binding to two key endocytic
proteins (14, 15). The second is filamin, an actin filament
cross-linking protein that mediates filopodia formation in neurites
(16).
Other small GTPases like Rho, Rac, or Cdc42 have about 30 identified
potential GTP-dependent binding proteins (17); however, only two are presently known for RalA. To better understand
RalA-mediated signaling pathways in neuronal cells our aim was to
identify new RalA-binding proteins in brain. We report on the
identification of eight specific GTP-dependent RalA-binding
proteins, which are proteins that comprise the mammalian exocyst
complex. The exocyst was first described in yeast as a complex of eight
proteins (Sec3p, Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, Exo70p, and
Exo84p) required for targeted exocytosis (18, 19). At least three of
these proteins are able to associate directly with three different
small GTPases in yeast (20-22). The mammalian equivalent of seven of the eight yeast exocyst proteins have been cloned (23-25). Our results
are the first to demonstrate that the mammalian exocyst also interacts
with small GTPases and suggests that, in addition to an established
role in endocytosis (14, 26) activated RalA may play a central role in
directing sites of exocytosis.
Recombinant RalA--
The bacterial expression vector containing
the wild-type RalA sequence fused to glutathione
S-transferase (GST), pGEX-2T-RalA, was provided by Yoshito
Kaziro (Yokohama, Japan). This vector was transformed into
Escherichia coli by heat shock. GST-RalA bound to GSH beads
(Amersham Pharmacia Biotech) was prepared according to the
manufacturer's instructions with the inclusion of 2.5 mM MgCl2 in all buffers.
Pull-down Experiments--
Crude synaptosomes (P2) were isolated
from three rats as described previously (27) and lysed with Triton
X-100 by resuspension in ice-cold lysis buffer (1% v/v Triton X-100,
25 mM Tris, pH 7.4, 150 mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 20 µg/ml
leupeptin, and 1 mM phenylmethylsulfonyl fluoride). Whole
rat tissue lysates were prepared by mincing 2 g of tissue, washing
in phosphate-buffered saline, and homogenizing equal tissue
weights in lysis buffer. All homogenates were centrifuged at
75,600 × g for 30 min at 4 °C. Protein-balanced
aliquots of the supernatant were precleared by the addition of
GSH-Sepharose for 30 min, pelleted at 50 × g for 5 min
at 4 °C, and the supernatant was collected. GST-RalA beads were
loaded with guanine nucleotides using established methods (13). A
volume of GSH beads containing ~10 µg of GST-RalA was incubated
with an equal volume of 20 mM Tris, pH 7.4, 10 mM EDTA, 25 mM NaCl, and 1 mM GDP
or GTP at 37 °C for 20 min. The buffer was adjusted to 10 mM MgCl2, then the tissue lysates were added and incubated at 4 °C for 1 h. The beads were isolated by
centrifugation at 50 × g for 5 min, transferred to
small empty spin columns (ProbeQuant G-50 Micro-columns, Amersham
Pharmacia Biotech) and washed three times with ice-cold lysis buffer
followed by three washes with 20 mM Tris, pH 7.4, containing 2.5 mM MgCl2. The samples were heated to 85 °C in SDS sample buffer for 5 min and collected into fresh tubes by centrifugation at 17,000 × g for 1 min.
Samples were run on SDS-PAGE and stained with Coomassie Brilliant Blue. For some experiments a cytosolic extract was prepared from 70 g of
sheep brain. Diced brain was washed with 20 mM Tris, pH
7.7, and homogenized in 20 mM Tris, pH 7.7, 1 mM CaCl2, 2 mM dithiothreitol, 10 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride using
an Ultra Turrax T25 homogenizer. The homogenate was centrifuged at 18,500 × g for 30 min at 4 °C. The extract was
adjusted to 3 mM EGTA (to chelate the
Ca2+).
Western Blotting--
Samples were subjected to SDS-PAGE on 12%
acrylamide minigels (Bio-Rad) and transferred to nitrocellulose
membrane (28). Proteins were detected by chemiluminescence (LumiLight
from Roche).
In-gel Digestion and MALDI-TOF MS--
Protein bands were
excised from Coomassie Blue-stained gels, rinsed with water, and
destained with several washes of 25 mM ammonium bicarbonate
in 50% acetonitrile. The gel pieces were dehydrated with 100%
acetonitrile and dried in a centrifugal evaporator. Sequencing grade
modified trypsin (Promega; 12.5 ng/µl in 50 mM ammonium
bicarbonate, pH 8.0) was added for 1 h at 4 °C and then incubated overnight at 37 °C. The resulting peptide mixture was collected and concentrated to a minimal volume in the centrifugal evaporator. An aliquot of the peptide mixture (1 µl) was spotted onto
the MALDI target plate and overlaid with 1 µl of
RalA-binding Proteins in Rat Tissues--
To identify possible new
RalA effector proteins, recombinant GST-RalA, coupled to GSH-Sepharose,
was loaded with either GDP or GTP and used as an affinity matrix to
isolate RalA-binding proteins from various rat tissue Triton X-100
lysates (Fig. 1). This approach isolates
GDP- or GTP-dependent RalA-binding proteins, as well as
proteins that might associate with these binding proteins. Recombinant
GST coupled to GSH-Sepharose was used as controls in parallel
experiments to provide a further degree of specificity (data not
shown). Four main proteins interacted specifically with GTP-bound
GST-RalA, compared with GDP-bound RalA in a preparation of rat brain
nerve terminals (synaptosomes, Fig. 1A, lanes 1 and 2). These were also abundant in whole brain lysates
(lanes 3 and 4), but were much less evident in
testis, lung, liver, and kidney (lanes 5-12). Protein 4, however, was present in testis and lung (lanes 6 and
8). While at least three proteins appeared to specifically associate with GDP-bound RalA compared with GTP-RalA in synaptosomes or
brain (lanes 1 and 3) and in kidney (lane
11), the GDP dependence of this association was not reproducible
in other experiments. Further pull-down experiments using larger
amounts of whole brain lysate yielded a number of additional proteins
that bound in a GTP-dependent manner and which were
previously undetectable by Coomassie Blue (Fig. 1B). Apart
from the four major bands six minor GTP-dependent bands
were detectable (marked with smaller arrows). Note that
bands 1 and 2 were not fully resolved on this gel, but their identities
were later confirmed by mass spectrometry to be the same as bands 1 and
2 of panel A (data not shown). This results in a total of 10 GTP-dependent RalA-binding proteins in whole rat brain.
RalA Associates with the Exocyst Complex--
MALDI-TOF MS was
utilized to identify the proteins that associated with GTP-bound RalA.
Unambiguous identification was achieved with all of the four major
RalA-binding proteins from synaptosomes and rat brain (Fig.
1A); however, none of the minor bands yielded unambiguous
identification at this stage. Proteins 1-4 were identified as rat Sec8
(rSec8), human hypothetical protein FLJ10893, rSec5, and rSec6,
respectively. Three of these were previously found to be components of
the mammalian exocyst complex (23-25).
To identify the minor bands we made two changes to the pull-down
experiments (Fig. 2A). First,
to obtain a much larger quantity of extract from brain, we changed
species to sheep. Second, we used only a cytosolic extract rather than
whole brain, as preliminary experiments suggested the
GTP-dependent binding proteins were predominantly cytosolic
(data not shown). Note that the migration of some of these proteins in
SDS-PAGE did not exactly match that found in rat brain. Eight distinct
GTP-dependent bands were detected. MALDI-TOF MS identified
all eight proteins as components of the exocyst complex (Fig.
2A). A representative MALDI-TOF MS peptide mass map obtained
for one of the mammalian exocyst proteins, rSec8, is shown in Fig.
2B. A large proportion of the peptide signals were
contributed by rSec8, yielding a statistically significant match with a
probability of greater than 99% (Table
I). A number of the other signals in the
spectrum were attributed to tryptic peptides from FLJ10893 (the
adjacent protein to rSec8 on the gel), GST-RalA, trypsin autolytic
peptides, and keratin. Similar high quality spectra were achieved for
all eight gel bands (data not shown), and probability scores for the
identities of the protein bands are shown in Table I. The purified
exocyst complex is known to contain at least eight proteins (23-25),
and all were identified by MALDI-TOF MS as associated with GTP-bound
RalA. However, the identification of Sec3 and Sec15 required further
analysis (see below). A number of the proteins that bound RalA in a
nucleotide-independent manner were identified as polymers of GST-RalA
(94 and 112 kDa, Fig. 2A, and four additional proteins
migrating as high as 150 kDa (data not shown)). The basis for the
appearance of the polymers is unknown, but polymers have been reported
by others (29).
The identification of the exocyst as a GTP-dependent RalA
binding complex by MALDI-TOF MS was confirmed by Western blotting with
specific antibodies to exocyst complex proteins (Fig.
3). Western blots of proteins from
pull-down experiments using rat synaptosome lysates revealed that rSec8
and rSec6 bound to GST-RalA in a GTP-dependent manner
(lanes 2 and 3). Neither was detectable in the
control pull-down using only GST coupled to GSH-beads (lane 1). rSec6 was also detected in samples of whole brain or testis lysate. To validate our method for the detection of RalA-binding proteins, we used immunoblots to detect two previously reported major
RalA-binding proteins. RalBP1 is a known GTP-dependent
RalA-binding protein (13), and PLD is known to associate with RalA
independently of its nucleotide-bound state (30). Both proteins were
appropriately detected in the pull-down experiments using rat brain
synaptosomes (Fig. 3).
Protein FLJ10893 Is a Mammalian Homologue of Yeast Sec3p--
The
sequence of the mammalian exocyst protein that is homologous to yeast
sec3p has not previously been reported. However it was proposed to
represent the rat brain exocyst p106 protein, and limited amino acid
sequence for p106 was previously published (24). In our study the
hypothetical human protein FLJ10893 (GenBankTM accession
number NP_060731) was identified as part of the complex binding to RalA
in a GTP-dependent manner. FLJ10893 is the only protein in
the complex we identified that was not recognized as a homologue of one
of the yeast exocyst proteins, but has a predicted mass corresponding
to p106. Therefore, we used bioinformatic tools to determine whether
FLJ10893 could be the mammalian homologue of yeast sec3p.
Alignment of amino acid sequences of FLJ10893 and yeast sec3p (which is
442 amino acids longer (144 kDa (18)) yielded significant identity
(14% identical residues using the PAM250 matrix, Fig. 4). Other yeast-mammalian exocyst
proteins exhibit about 12-21% overall identity. FLJ10893 is the only
human protein in the nonredundant data base with significant identity
to yeast Sec3p. BLAST searches were used to establish an evolutionary
relationship between FLJ10893 and yeast Sec3p. Significant matches were
obtained to uncharacterized gene products from several species:
Mus musculus AK013041 (E value = e KIAA0919 Protein as a Novel Human Sec15p Homologue--
The
GTP-dependent RalA-binding protein that corresponds to the
yeast exocyst complex protein Sec15p was identified as KIAA0919 protein
with a >99% probability by MALDI-TOF MS. A rat Sec15p homologue has
previously been cloned (25), but surprisingly only a nonsignificant
match (>80% probability) was obtained by MALDI-TOF MS for this
protein in our study. With the view that KIAA0919 may be a new human
variant of rSec15, we searched the human nonredundant data
base using the sequence of rSec15 for similar proteins. One human entry
(GenBankTM accession number CAB70736) was 93% identical to
rSec15 (although it is truncated by 250 amino acids at the N terminus). Therefore CAB70736 represents the human form of rSec15, and we called
it hSec15A. KIAA0919 was only 67% identical and 79% similar to
rSec15, indicating that it is a second Sec15
gene, which we named hSec15B. hSec15A and hSec15B share
66% identity and 75% similarity. The hSec15B/KIAA0919 nucleotide
sequence lacks a defined start codon, suggesting that it is an
incomplete sequence. Therefore, the existence of a rat protein product
for hSec15B/KIAA0919 is possible, but so far uncharacterized. When we
compared the peptides from rat brain exocyst complex protein p96 from
Hsu et al. (24) with hSec15B/KIAA0919, three out of five
peptides matched better to the hSec15B/KIAA0919 sequence than to the
sequence of rSec15. We conclude that there are two human orthologues of
yeast Sec15p and that we have identified hSec15B/KIAA0919 as the Sec15 component of the exocyst complex that interacts with RalA.
The main finding of this study is that the GTPase RalA interacts
with at least eight proteins in brain in a GTP-dependent manner. Eight of these were identified either as known components of
the mammalian exocyst complex or as homologues of known exocyst proteins. Therefore the exocyst is a novel effector for RalA. We also
report the first identification of the mammalian Sec3 protein and show
that mammalian Sec15 exists as at least two gene products,
hSec15A and hSec15B. Sec3p and Sec15p are two of
the three yeast exocyst proteins known to bind small GTPases, these being Rho1p and Sec4p, respectively (20, 22). The exocyst complex was
initially characterized in yeast as a multiprotein complex thought to
be involved in polarized secretion and which localizes to sites of
active exocytosis in bud tips (18). The yeast exocyst complex consists
of eight characterized proteins, named Sec3p, Sec8p, Sec15p, Sec5p,
Sec10p, Sec6p, Exo84p, and Exo70p, of molecular masses 144, 131, 113, 107, 100, 88, 84, and 70 kDa, respectively (18, 19). Specific mutations
in these proteins lead to a phenotypic temperature-sensitive deficiency in invertase secretion and an accumulation of secretory vesicles in the
cytoplasm (31). The mammalian exocyst complex was later characterized
from rat brain and also found to be composed of a corresponding set of
eight proteins (24). Seven of the exocyst genes have been cloned from
rat brain, and these were named rSec8, rSec5, rSec15, rSec6, rExo84,
rExo70, and rSec10, with molecular masses 110, 102, 96, 86, 84, 79, and
71 kDa, respectively (23, 25). An eighth protein of 106 kDa has also
been found in the purified exocyst and is likely to be a mammalian
homologue of the yeast Sec3p, but it is yet to be cloned (24).
The finding that the exocyst complex associates with RalA in a
GTP-dependent manner was confirmed in three independent
approaches in our study. Initially, four major and six minor proteins
were detected in whole rat brain lysates. The four major proteins were readily identified by MALDI-TOF MS tryptic peptide mass mapping as
rSec8, FLJ10893, rSec5, and rSec6. The six minor proteins have yet to
be identified from rat, but likely candidates are RalBP1 and the
remaining four exocyst proteins. Second, scaled up experiments with
sheep brain cytosol resulted in clear tryptic peptide mass maps from
all eight sheep proteins. Six were known exocyst proteins and two were
novel genes, which we established as related to exocyst proteins.
Identification of proteins by peptide mass mapping uses data drawn from
the entire nonredundant data base. Thus, rSec8, hSec5, hExo84, rSec6,
mExo70, and hSec10 were identified from either rat and sheep brain as
statistically significant matches, despite that some of these are human
(h) or mouse (m) sequences. This method is readily able to identify
proteins from different species if the sequences are sufficiently
identical (such as between different mammalian species for example)
(32). Third, rSec8 and rSec6 were confirmed by Western blotting to bind
to RalA in a GTP-dependent manner. Apart from the known
exocyst proteins, two additional proteins were also identified by mass
spectrometry: both are hypothetical sequences from the human genome
that have not been otherwise characterized. One identifies a candidate
human Sec3 protein as FLJ10893 and the other is a second human
Sec15 gene, hSec15B/KIAA0919.
A mammalian homologue of yeast Sec3p is the only exocyst protein not
previously cloned from vertebrates. Sec3p in yeast may anchor the
exocyst to the plasma membrane, and has been termed a "spatial
landmark" for polarized secretion (33, 34). We matched the peptide
mass maps of a sheep brain 100-kDa protein to human FLJ10893, which has
sequence similarity to yeast sec3p. The identification of FLJ10893 as a
candidate mammalian Sec3 was supported by its similar molecular mass,
sequence homology, and that amino acid sequences from the rat exocyst
protein p106 (24) also closely match FLJ10893. However, this
identification needs to be confirmed by cloning the equivalent gene
from rat or sheep.
Two Sec15 genes were identified in this study. Sec15
from rat was previously cloned (25), and we found a human
homologue from GenBankTM, which we named hSec15A/CAB70736.
However, the MS data did not identify the 92-kDa component of the
RalA-binding exocyst complex as Sec15A. The statistically significant
match was to KIAA0919, a novel homologue of Sec15, which we named
hSec15B/KIAA0919. The proteins are 72% identical in their core region,
but have distinct N- or C-terminal extensions. Furthermore, aligning
the rat tryptic peptide sequences obtained by Hsu et al.
(24) with hSec15B/KIAA0919 produces a much better match than to
hSec15A/CAB70736 or to rSec15. This raises the possibility that the
mammalian Sec15 exists in two forms and that the B form is a component
of the exocyst complex that interacts with RalA. Other mammalian
exocyst proteins may arise from multiple genes, for example Sec6 and
B94 (25).
RalA is the first mammalian protein shown to interact with the exocyst
in a GTP-dependent manner. It is unlikely that RalA interacts with all eight proteins, but the specific exocyst protein target for RalA has not been determined. Specific components of the
yeast exocyst are known to associate with at least three small GTPases.
Sec4p (the yeast equivalent of Rab3A) anchors the complex to secretory
vesicles via Sec15p (20), Rho1p anchors it to the plasma membrane via
Sec3p (22), and Rho3p binds Exo70p (21). As there is no yeast
equivalent of Ral (the closest related proteins being the Ras proteins)
it is difficult to speculate on a function for the RalA-exocyst
interaction based on the known small GTPase-exocyst interactions in
yeast. RalA is localized both on secretory vesicles and on the plasma
membrane (3, 4) and, like Rab3A (35), undergoes reversible association
with synaptic vesicle membranes (10). Therefore, it will be important
to determine whether the mammalian RalA-exocyst interaction might mimic
the yeast Sec15p-Sec4p interaction in tethering the complex to synaptic
vesicles, the Sec3p-Rho1p interaction in tethering the complex to the
plasma membrane, or whether there is a novel function.
Our results localize the exocyst and most of the known Ral signaling
pathway to nerve terminals, which are regions of neuronal cells highly
adapted for secretory roles. RalA regulates receptor-mediated endocytosis in nonneuronal cells via its effector RalBP1 (14). Another
protein directly activated by RalA is PLD1, which is also required for
endocytosis (12). Our results localize these two signaling pathways to
nerve terminals, sites of extremely active synaptic vesicle
endocytosis, but it remains to be demonstrated whether RalA has an
endocytic role in the nerve terminal. Our finding that the exocyst is
another effector for RalA localizes this complex to the mature nerve
terminal. The complex was previously localized to growth cones of axons
and dendrites in developing neurons, in discrete domains along the
axon, and in most newly formed nerve terminals (36). The likely role
for the mammalian exocyst in the development of nerve terminal
exocytosis and the established role for RalA in endocytosis places RalA
in a unique situation where it potentially regulates both, although not
necessarily during the same stage of development. Exocytosis and
endocytosis in nerve terminals is
Ca2+-dependent, and RalA is also activated by
Ca2+-calmodulin (8, 9). Thus, the possible role of RalA in
synaptic vesicle recycling in neurons now needs to be more clearly
established. A dynamic interaction of the exocyst with synaptic vesicle
and plasma membrane-bound small GTPases is compatible with current views of the cellular function of the exocyst. RalA also recruits filamin in a GTP-dependent manner to specific sites on the
plasma membrane and has been proposed to thereby induce filopodia
formation (16). The exocyst complex is required for exocytosis and
neurite outgrowth, and it localizes to filopodia and neurite growth
cones. Therefore, RalA might be acting as a control point for the
integration of receptor and calcium signaling with neurite outgrowth,
endocytosis, and directing sites of exocytosis.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyano-4-hydroxycinnamic acid solution (20 mg/ml in 100%
acetonitrile). A Voyager-DE STR MALDI mass spectrometer (Applied
Biosystems) equipped with delayed extraction was employed for peptide
mass mapping in positive reflector mode. Peptide mass maps were
searched against theoretically derived maps from proteins in the
nonredundant protein data base (NCBI) using the ProFound online program
(www.proteometrics.com). Theoretical digests were obtained through
the online MS-Digest program (prospector.ucsf.edu). Similarity searches
against the nonredundant protein data base were performed using BLAST
from NCBI. Proteins were aligned using AntheProt version 5.0 software
(pbil.ibcp.fr/~deleage/) or ClustalW at EBI (www2.ebi.ac.uk).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (67K):
[in a new window]
Fig. 1.
Detection of proteins in rat tissues that
bind RalA in a nucleotide-dependent manner.
A, RalA associates in a GTP-dependent manner
with four major proteins in rat brain synaptosomes and whole rat brain.
GST-RalA bound to GSH-Sepharose was loaded with GDP or GTP and used in
pull-down experiments from whole lysates of rat brain synaptosomes and
various rat tissues. Bound proteins were analyzed by SDS-PAGE and
stained with Coomassie blue. B, RalA associates in a
GTP-dependent manner with 10 proteins in rat brain. A
GST-RalA pull-down from whole rat brain lysate was performed as
described in panel A, but from a greater amount of lysate.
The four major GTP-dependent RalA-binding proteins seen in
panel A are indicated, numbered 1-4. Note that proteins 1 and 2 of the gel in panel A comigrate in the gel in
panel B.

View larger version (50K):
[in a new window]
Fig. 2.
RalA associates with the exocyst complex in
brain. A, a GST-RalA pull-down experiment
was performed as in Fig. 1, but from sheep brain cytosol. Each
indicated band was analyzed by MALDI-TOF mass spectrometry. The protein
identified by MALDI-MS in each band is indicated. B,
MALDI-MS peptide mass map of rSec8. This spectrum is representative of
data obtained by MALDI-MS for all the marked bands in panel
A. Peptide signals that correspond to theoretical in
silico digests of each protein component are indicated.
Identification of GTP-dependent RalA binding proteins in
sheep brain cytosol
95%.

View larger version (51K):
[in a new window]
Fig. 3.
Exocyst complex proteins are identified as
GTP-dependent RalA-binding proteins by Western
blotting. Pull-down experiments using GSH beads bound to
recombinant GST or to GST-RalA loaded with GDP or GTP were performed
from rat brain synaptosomes and whole tissues. Bound proteins were
analyzed by Western blot using anti-rSec8 and anti-rSec6 monoclonal
antibodies (StressGen) and anti-PLD and anti-RalBP1 polyclonal
antibodies (Santa Cruz).
129, 97% identity and 98% similarity),
Drosophila melanogaster CG3885 (E value = e
180, 40% identity and 60% similarity),
Caenorhabditis elegans F52E4.7 (E value = e
125 33% identity and 52% similarity), and
Arabidopsis thaliana A007519 (E value = e
53, 23% identity and 42% similarity). In each case, no
other gene products were related. We conclude that each of these
proteins represents a FLJ10893 homologue in each of these species. We
next investigated the relationship between these genes and the entire yeast genome. Only one significant match was found for each of these
genes, yeast Sec3p (for D. melanogaster CG3885: E
value = 6e
7, 19% identity and 38% similarity, Fig.
4). Finally, we searched for amino acid sequences of tryptic peptides
obtained previously for the rat brain exocyst protein p106 to determine
whether they were found in FLJ10893 (24). Two of the six peptides from
p106 closely match FLJ10893: ELPEFNLHFF (FLJ10893
86ENPEFDLHFE94) and xLQDVDLASxR (FLJ10893
289ALQEGDLASSR299) (overlined in
Fig. 4). Thus, the hypothetical human protein FLJ10893 likely
represents the first description of a mammalian homologue of the yeast
Sec3p protein.

View larger version (73K):
[in a new window]
Fig. 4.
Identification of human hypothetical protein
FLJ10893 as the mammalian homologue of yeast Sec3p. The amino acid
sequence of FLJ10893 protein (hum) was aligned with the
homologous sequence from D. melanogaster CG3885
(fly) and from yeast Sec3p (yea) using ClustalW.
Identical amino acids are shown in white text on a black
background, while similar amino acids are shown against a
gray background. Regions matching Edman sequence reported
previously (24) for tryptic digests of the rat brain exocyst protein
p106 are overlined.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Peter Rowe for critical reading of the manuscript and George Smythe, Martin Bucknall, and the staff of the Ray Williams Biomedical Mass Spectrometry Facility at the University of New South Wales for help and access to the Voyager DE STR instrument.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the Australian National Health and Medical Research Council (to B. D. R. and to P. J. R.) and the Danish Natural Science Research Council (to M. R. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Cell Signaling
Unit, Children's Medical Research Institute, Locked Bag 23, Wentworthville 2145, NSW, Australia. Tel.: 61-2-9687-2800; Fax:
61-2-9687-2120; E-mail: phrobins@mail.usyd.edu.au.
Published, JBC Papers in Press, June 13, 2001, DOI 10.1074/jbc.C100320200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GEF, guanine nucleotide exchange factor; PLD, phospholipase D; GST, glutathione S-transferase; MALDI-TOF MS, matrix-assisted laser desorption ionization time-of-flight mass spectrometry; PAGE, polyacrylamide gel electrophoresis.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Chardin, P., and Tavitian, A. (1989) Nucleic Acids Res. 17, 4380 |
| 2. | Bhullar, R. P., and Yang, S. (1998) Mol. Cell. Biochem. 179, 49-55 |
| 3. | Jilkina, O., and Bhullar, R. P. (1996) Biochim. Biophys. Acta 1314, 157-166 |
| 4. | Bielinski, D. F., Pyun, H. Y., Linko-Stentz, K., Macara, I. G., and Fine, R. E. (1993) Biochim. Biophys. Acta 1151, 246-256 |
| 5. | Reuther, G. W., and Der, C. J. (2000) Curr. Opin. Cell Biol. 12, 157-165 |
| 6. | de Bruyn, K. M., de Rooij, J., Wolthuis, R. M., Rehmann, H., Wesenbeek, J., Cool, R. H., Wittinghofer, A. H., and Bos, J. L. (2000) J. Biol. Chem. 275, 29761-29766 |
| 7. | Hofer, F., Berdeaux, R., and Martin, G. S. (1998) Curr. Biol. 8, 839-842 |
| 8. | Wang, K. L., Khan, M. T., and Roufogalis, B. D. (1997) J. Biol. Chem. 272, 16002-16009 |
| 9. | Wang, K. L., and Roufogalis, B. D. (1999) J. Biol. Chem. 274, 14525-14528 |
| 10. | Park, J. B., Lee, J. Y., and Kim, J. W. (1999) Biochem. Biophys. Res. Commun. 263, 765-769 |
| 11. | Luo, J. Q., Liu, X., Frankel, P., Rotunda, T., Ramos, M., Flom, J., Jiang, H., Feig, L. A., Morris, A. J., Kahn, R. A., and Foster, D. A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 3632-3637 |
| 12. | Shen, Y., Xu, L., and Foster, D. A. (2001) Mol. Cell. Biol. 21, 595-602 |
| 13. | Cantor, S. B., Urano, T., and Feig, L. A. (1995) Mol. Cell. Biol. 15, 4578-4584 |
| 14. | Nakashima, S., Morinaka, K., Koyama, S., Ikeda, M., Kishida, M., Okawa, K., Iwamatsu, A., Kishida, S., and Kikuchi, A. (1999) EMBO J. 18, 3629-3642 |
| 15. | Jullien-Flores, V., Mahe, Y., Mirey, G., Leprince, C., Meunier-Bisceuil, B., Sorkin, A., and Camonis, J. H. (2000) J. Cell Sci. 113, 2837-2844 |
| 16. | Ohta, Y., Suzuki, N., Nakamura, S., Hartwig, J. H., and Stossel, T. P. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2122-2128 |
| 17. | Bishop, A. L., and Hall, A. (2000) Biochem. J. 348, 241-255 |
| 18. | TerBush, D. R., Maurice, T., Roth, D., and Novick, P. (1996) EMBO J. 15, 6483-6494 |
| 19. | Guo, W., Grant, A., and Novick, P. (1999) J. Biol. Chem. 274, 23558-23564 |
| 20. | Harsay, E., and Bretscher, A. (1995) J. Cell Biol. 131, 297-310 |
| 21. | Robinson, N. G., Guo, L., Imai, J., Toh, E., Matsui, Y., and Tamanoi, F. (1999) Mol. Cell. Biol. 19, 3580-3587 |
| 22. | Guo, W., Tamanoi, F., and Novick, P. (2001) Nat. Cell Biol. 3, 353-360 |
| 23. | Ting, A. E., Hazuka, C. D., Hsu, S. C., Kirk, M. D., Bean, A. J., and Scheller, R. H. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9613-9617 |
| 24. | Hsu, S. C., Ting, A. E., Hazuka, C. D., Davanger, S., Kenny, J. W., Kee, Y., and Scheller, R. H. (1996) Neuron 17, 1209-1219 |
| 25. | Kee, Y., Yoo, J. S., Hazuka, C. D., Peterson, K. E., Hsu, S. C., and Scheller, R. H. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 14438-14443 |
| 26. | Morinaka, K., Koyama, S., Nakashima, S., Hinoi, T., Okawa, K., Iwamatsu, A., and Kikuchi, A. (1999) Oncogene 18, 5915-5922 |
| 27. | Robinson, P. J., and Dunkley, P. R. (1983) J. Neurochem. 41, 909-918 |
| 28. | Towbin, H., Staehlin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354 |
| 29. | Doucet, A., and Beauregard, M. (2001) Anal. Biochem. 292, 296-297 |
| 30. | Luo, J. Q., Liu, X., Hammond, S. M., Colley, W. C., Feig, L. A., Frohman, M. A., Morris, A. J., and Foster, D. A. (1997) Biochem. Biophys. Res. Commun. 235, 854-859 |
| 31. | Novick, P., Field, C., and Schekman, R. (1980) Cell 21, 205-215 |
| 32. | Larsen, M. R., and Roepstorff, P. (2000) Fresenius' J. Anal. Chem. 366, 677-690 |
| 33. | Finger, F. P., and Novick, P. (1997) Mol. Biol. Cell 8, 647-662 |
| 34. | Finger, F. P., Hughes, T. E., and Novick, P. (1998) Cell 92, 559-571 |
| 35. | Fischer von Mollard, G., Stahl, B., Khokhlatchev, A., Südhof, T. C., and Jahn, R. (1994) J. Biol. Chem. 269, 10971-10974 |
| 36. | Hazuka, C. D., Foletti, D. L., Hsu, S. C., Kee, Y., Hopf, F. W., and Scheller, R. H. (1999) J. Neurosci. 19, 1324-1334 |
This article has been cited by other articles:
![]() |
M. G. Rondaij, R. Bierings, E. L. van Agtmaal, K. A. Gijzen, E. Sellink, A. Kragt, S. S. G. Ferguson, K. Mertens, M. J. Hannah, J. A. van Mourik, et al. Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells Blood, July 1, 2008; 112(1): 56 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lopez, E. P. Kwan, L. Xie, Y. He, D. E. James, and H. Y. Gaisano The RalA GTPase Is a Central Regulator of Insulin Exocytosis from Pancreatic Islet Beta Cells J. Biol. Chem., June 27, 2008; 283(26): 17939 - 17945. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hao, R. Wong, and L. A. Feig RalGDS Couples Growth Factor Signaling to Akt Activation Mol. Cell. Biol., May 1, 2008; 28(9): 2851 - 2859. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hala, R. Cole, L. Synek, E. Drdova, T. Pecenkova, A. Nordheim, T. Lamkemeyer, J. Madlung, F. Hochholdinger, J. E. Fowler, et al. An Exocyst Complex Functions in Plant Cell Growth in Arabidopsis and Tobacco PLANT CELL, May 1, 2008; 20(5): 1330 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawato, R. Shirakawa, H. Kondo, T. Higashi, T. Ikeda, K. Okawa, S. Fukai, O. Nureki, T. Kita, and H. Horiuchi Regulation of Platelet Dense Granule Secretion by the Ral GTPase-Exocyst Pathway J. Biol. Chem., January 4, 2008; 283(1): 166 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Falsetti, D.-a. Wang, H. Peng, D. Carrico, A. D. Cox, C. J. Der, A. D. Hamilton, and S. M. Sebti Geranylgeranyltransferase I Inhibitors Target RalB To Inhibit Anchorage-Dependent Growth and Induce Apoptosis and RalA To Inhibit Anchorage-Independent Growth Mol. Cell. Biol., November 15, 2007; 27(22): 8003 - 8014. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, L. Han, T.-C. Chou, Y. Fujita, L. Arunachalam, A. Xu, A. Wong, S.-K. Chiew, Q. Wan, L. Wang, et al. RalA and RalB Function as the Critical GTP Sensors for GTP-Dependent Exocytosis J. Neurosci., January 3, 2007; 27(1): 190 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Balakireva, C. Rosse, J. Langevin, Y.-c. Chien, M. Gho, G. Gonzy-Treboul, S. Voegeling-Lemaire, S. Aresta, J.-A. Lepesant, Y. Bellaiche, et al. The Ral/Exocyst Effector Complex Counters c-Jun N-Terminal Kinase-Dependent Apoptosis in Drosophila melanogaster Mol. Cell. Biol., December 1, 2006; 26(23): 8953 - 8963. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Grosshans, D. Ortiz, and P. Novick Rabs and their effectors: Achieving specificity in membrane traffic PNAS, August 8, 2006; 103(32): 11821 - 11827. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blanke and H. Jackle Novel guanine nucleotide exchange factor GEFmeso of Drosophila melanogaster interacts with Ral and Rho GTPase Cdc42 FASEB J, April 1, 2006; 20(6): 683 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Anitei, M. Ifrim, M.-A. Ewart, A. E. Cowan, J. H. Carson, R. Bansal, and S. E. Pfeiffer A role for Sec8 in oligodendrocyte morphological differentiation J. Cell Sci., March 1, 2006; 119(5): 807 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rosse, A. Hatzoglou, M.-C. Parrini, M. A. White, P. Chavrier, and J. Camonis RalB Mobilizes the Exocyst To Drive Cell Migration Mol. Cell. Biol., January 15, 2006; 26(2): 727 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vitale, J. Mawet, J. Camonis, R. Regazzi, M.-F. Bader, and S. Chasserot-Golaz The Small GTPase RalA Controls Exocytosis of Large Dense Core Secretory Granules by Interacting with ARF6-dependent Phospholipase D1 J. Biol. Chem., August 19, 2005; 280(33): 29921 - 29928. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuboi, M. A. Ravier, H. Xie, M.-A. Ewart, G. W. Gould, S. A. Baldwin, and G. A. Rutter Mammalian Exocyst Complex Is Required for the Docking Step of Insulin Vesicle Exocytosis J. Biol. Chem., July 8, 2005; 280(27): 25565 - 25570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murthy, R. Ranjan, N. Denef, M. E. L. Higashi, T. Schupbach, and T. L. Schwarz Sec6 mutations and the Drosophila exocyst complex J. Cell Sci., March 15, 2005; 118(6): 1139 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boyd, T. Hughes, M. Pypaert, and P. Novick Vesicles carry most exocyst subunits to exocytic sites marked by the remaining two subunits, Sec3p and Exo70p J. Cell Biol., December 6, 2004; 167(5): 889 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Zhang, S. Ellis, A. Sriratana, C. A. Mitchell, and T. Rowe Sec15 Is an Effector for the Rab11 GTPase in Mammalian Cells J. Biol. Chem., October 8, 2004; 279(41): 43027 - 43034. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shipitsin and L. A. Feig RalA but Not RalB Enhances Polarized Delivery of Membrane Proteins to the Basolateral Surface of Epithelial Cells Mol. Cell. Biol., July 1, 2004; 24(13): 5746 - 5756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Dubin, P. H. Stokes, E. Y. M. Sum, R. S. Williams, V. A. Valova, P. J. Robinson, G. J. Lindeman, J. N. M. Glover, J. E. Visvader, and J. M. Matthews Dimerization of CtIP, a BRCA1- and CtBP-interacting Protein, Is Mediated by an N-terminal Coiled-coil Motif J. Biol. Chem., June 25, 2004; 279(26): 26932 - 26938. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, G. Li, and S. Sugita RalA-Exocyst Interaction Mediates GTP-dependent Exocytosis J. Biol. Chem., May 7, 2004; 279(19): 19875 - 19881. [Abstract] [Full Text] [PDF] |
||||
![]() |